Your session is about to expire
Gentamicin vs Tobrex
Introduction
For patients with bacterial eye infections, certain drugs that prevent the growth of or kill bacteria can help in managing symptoms and treating the condition. Gentamicin and Tobrex (generic name: tobramycin) are two such antibiotics that are prescribed for these types of infections. They each combat different strains of bacteria but both have antibacterial effects in patients with eye infections. Gentamicin is an aminoglycoside antibiotic which works by binding to the 30S subunit of the bacterial ribosome, inhibiting protein synthesis and leading to cell death. Tobrex, on the other hand, is also classified as an aminoglycoside antibiotic and it too binds to bacterial ribosomes resulting in incorrect alignment during protein synthesis thus killing bacteria effectively.
Gentamicin vs Tobrex Side By Side
| Attribute | Gentamicin | Tobrex |
|---|---|---|
| Brand Name | Gentamicin | Tobrex |
| Contraindications | Previous hypersensitivity reaction to any aminoglycoside antibiotics, use of neuromuscular blocking agents or botulinum toxin. | Previous hypersensitivity reaction to any aminoglycoside antibiotics. |
| Cost | For the brand name, about $10 for a 2ml vial. Generic versions average around half that of the branded version. | For the brand name, about $185 for a 5ml bottle. Generic Tobramycin costs range from $10 to $30 for a similar size bottle. |
| Generic Name | Gentamicin | Tobramycin |
| Most Serious Side Effect | Kidney problems, nerve damage symptoms, hearing loss, symptoms of overdose. | Signs of an allergic reaction or severe skin reaction, changes in vision, severe burning or discomfort, signs of a new infection, unusual changes in mood or behavior. |
| Severe Drug Interactions | Neuromuscular blocking agents, botulinum toxin. | Not specifically mentioned, but caution is advised with any drugs known to interact with aminoglycosides. |
| Typical Dose | For eye infections, one to two drops in the affected eye(s) every four hours, not to exceed eight times per day. | 1–2 drops in the affected eye(s) every four hours, can be increased to every two hours depending on severity. Maximum dose and duration vary based on physician's recommendation. |
What is Gentamicin?
Gentamicin (known under various trade names) is an aminoglycoside antibiotic used to treat several types of bacterial infections, particularly those caused by Gram-negative bacteria. Gentamicin was first approved by the FDA in 1963. It works by binding to the subunit of the bacterial ribosome, inhibiting protein synthesis and leading to bacterial cell death. Gentamicin is administered intravenously or topically for eye infections.
Tobramycin (sold as Tobrex among other brand names) also belongs to the aminoglycoside class of antibiotics and has similar antibacterial properties as gentamicin. However, it's primarily used for Pseudomonas aeruginosa and Staphylococcus infections including conjunctivitis in topical form.
Both drugs have potential side effects such as kidney damage and hearing loss due to their ototoxicity and nephrotoxicity, but these are more common with systemic use rather than topical application on eyes. In summary, choice between these two will depend upon sensitivity pattern of organisms causing infection.
What conditions is Gentamicin approved to treat?
Gentamicin is authorized for the treatment of a variety of bacterial infections:
- Severe or serious bacterial infections that cannot be treated with other antibiotics
- Certain types of pneumonia and skin, bone, stomach, blood, and urinary tract infections
- It can also be used in combination with other medications to treat tuberculosis (TB)
While Tobrex (tobramycin) is approved for topical use to manage a range of eye conditions:
- Conjunctivitis caused by susceptible bacteria
- Corneal ulcers associated with susceptible gram-negative and gram-positive bacteria
- Other superficial ocular infections due to susceptible strains of bacteria.
How does Gentamicin help with these illnesses?
Gentamicin is an aminoglycoside antibiotic that helps to treat bacterial infections by inhibiting protein synthesis in bacteria, leading to their death. It does this by binding to the 30S subunit of the bacterial ribosome, thereby disrupting the initiation and elongation steps of protein synthesis. Gentamicin is effective against a variety of gram-negative and gram-positive bacteria.
Tobrex (tobramycin), on the other hand, also belongs to the group of aminoglycoside antibiotics. Its mechanism of action is similar to gentamicin as it binds to the 30S ribosomal subunit in susceptible bacteria causing misreading and premature termination during translation process leading ultimately to bacterial cell death.
The choice between these two drugs often comes down to which specific strain of bacterium one needs treatment for since different species may exhibit varying degrees of susceptibility towards these medications. Furthermore, both medications can potentially cause ototoxicity or nephrotoxicity so they should be used judiciously under guidance from healthcare professionals.
What is Tobrex?
Tobrex, the brand name for tobramycin, is an aminoglycoside antibiotic used predominantly in eye infections. It functions by preventing bacteria from producing proteins necessary for their growth and replication. Tobramycin was first approved by the FDA in 1980. As it does not inhibit bacterial cell wall synthesis like other classes of antibiotics (such as penicillins), its mode of action and side-effect profile are unique. In particular, unlike gentamicin which can cause ototoxicity and nephrotoxicity when administered systemically, Tobrex primarily causes local irritation such as stinging or burning sensations upon administration due to its topical use as eye drops or ointment. Its effects on inhibiting protein synthesis in bacteria can be beneficial especially against Pseudomonas aeruginosa - a common causative agent of bacterial conjunctivitis that does not respond well to "typical" antibiotics like gentamicin.
What conditions is Tobrex approved to treat?
Tobrex, also known by its generic name tobramycin, is an antibiotic eye drop that's approved for treating bacterial infections of the eyes. It can effectively treat conditions such as:
- Conjunctivitis (commonly referred to as "pink eye")
- Keratitis
- Other serious eye infections caused by susceptible bacteria.
It's important to note that Tobrex should be used under a healthcare professional’s guidance due to potential side effects such as irritation or discomfort in the eye and sensitivity reactions.
How does Tobrex help with these illnesses?
Tobramycin, the active ingredient in Tobrex, is an aminoglycoside antibiotic that prevents bacteria from producing proteins essential to their growth. It plays roles in many processes within bacterial cells, affecting protein synthesis and compromising cell membrane integrity. This makes it highly effective against a broad spectrum of bacterial infections particularly those impacting the eye such as conjunctivitis or corneal ulcers. While gentamicin also works by inhibiting protein synthesis, its broader range can sometimes lead to higher risks of side effects like kidney damage and hearing loss. Tobrex has been specifically formulated for ocular use so it's generally better tolerated with fewer systemic side effects compared to gentamicin when used for treating eye infections. Thus, if a patient does not respond well or has contraindications for other antibiotics (such as Gentamicin), then Tobrex might be prescribed either alone or combined with other treatments.
How effective are both Gentamicin and Tobrex?
Both gentamicin and tobramycin (Tobrex) are aminoglycoside antibiotics that have been successfully used for decades in treating serious bacterial infections. They were initially approved by the FDA only few years apart, with gentamicin being approved first. Although they act on similar types of bacteria, their individual effectiveness may vary based on the specific bacterial strain causing an infection.
Their efficacy was directly studied in numerous clinical trials over the years; both drugs exhibited similar ability in controlling certain bacterial infections as well as comparable safety profiles. In these studies, none of the different metrics studied to measure efficacy against particular types of bacteria differed substantively between patients receiving gentamicin or those receiving tobramycin.
A 2007 review indicated that gentamicin appears effective from the onset of treatment and its side effect profile is generally manageable compared to many other antibiotics used for severe infections. It has become one of the most widely prescribed aminoglycosides worldwide due to its broad-spectrum activity against several Gram-negative organisms including Pseudomonas aeruginosa.
On the other hand, a 2014 meta-analysis suggested that Tobramycin seems equally effective as other common aminoglycosides like Gentamicin but can be preferred in cases where there is resistance or reduced sensitivity towards Gentamicin. While Tobramycin is considered a mainstay treatment option for Pseudomonas aeruginosa infections, it's typically administered alongside another antibiotic so data confirming its efficacy as standalone treatment isn't as robust compared to Gentamicin. Nonetheless, due to unique pharmacology and less ototoxicity than Gentamicin, Tobramycin could be optimal choice for patients who did not respond well or have contraindications such as kidney disease or hearing problems.
Related trials for gentamicin and tobrex
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Gentamicin typically prescribed?
Dosages of Gentamicin for eye infections typically range from one to two drops in the affected eye(s) every four hours, or as directed by your healthcare provider. For children and adolescents, the dosage may be adjusted according to severity of infection and response to treatment. The maximum dosage should not exceed more than eight times per day. Similarly, Tobrex (Tobramycin) is usually prescribed as one or two drops into the affected eye(s) every four hours. In severe infections, this can be increased up to every hour under close medical supervision. Always consult with a healthcare provider before changing dosages.
At what dose is Tobrex typically prescribed?
Tobrex eye drop treatment is generally started with a dosage of 1–2 drops in the affected eye(s) every four hours. Frequency can then be increased to every two hours while awake, depending on the severity of the infection. The maximum dose varies based on your physician's recommendation and it should not exceed more than 9 times per day for adults or children above one year old. Treatment duration usually lasts for seven days but may be prolonged if there is no significant response after a week of use under your doctor's discretion.
What are the most common side effects for Gentamicin?
Common side effects of Gentamicin and Tobrex, both antibiotics used to treat bacterial eye infections, can include:
- Local irritation or burning
- Itchiness in the eyes
- Redness of the conjunctiva (the white part of your eye)
- Mild stinging sensation
- Slight increase in tear production
- Hypersensitivity reactions such as rashes, itching, swelling around the eyes.
These medications are not typically associated with systemic side effects like anxiety, insomnia or digestive issues since they're administered topically into the eye. However, if there's a severe allergic reaction or if new symptoms develop after starting these medications (like vision changes), immediate medical attention is required.
Are there any potential serious side effects for Gentamicin?
Though rare, Gentamicin can have serious side effects that need immediate medical attention. These include:
- Signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat
- Kidney problems - little or no urinating; painful or difficult urination; swelling in your feet or ankles; feeling tired or short of breath
- Nerve damage symptoms - muscle twitching, numbness and tingling (especially in the hands and feet), weakness
- Hearing loss - ringing in your ears, dizziness (vertigo), difficulty with balance
- Symptoms of overdose - severe stomach pain/discomfort/cramps
On the other hand Tobrex has a more favorable safety profile but it's not without potential risks. Some patients may experience:
- Eye discomfort/itching/redness/swelling
- Rash around eyes
- Difficulty breathing
If any above mentioned symptoms occur while using either medication you should immediately seek medical attention.
What are the most common side effects for Tobrex?
Tobrex, also known as tobramycin, may result in the following side effects:
- Mild eye irritation or burning
- Stinging upon application
- Eyelid swelling
- Redness of the eyes
- Itching sensation in the eyes
- Temporary blurred vision
These side effects are generally mild and tend to subside soon after treatment. However, if they persist or become more severe, it's advisable to consult your healthcare provider immediately.
Are there any potential serious side effects for Tobrex?
While Tobrex is generally well-tolerated, some individuals may experience potentially serious side effects. These can include:
- Signs of an allergic reaction or severe skin reaction: hives, itching, fever, swollen glands, difficulty breathing, swelling in your face or throat
- Changes in vision such as blurred vision or eye pain
- Severe burning or other discomfort after using the eye drops
- Signs of a new infection such as redness that worsens and pus formation
- Unusual changes in mood or behavior; these could indicate neurological reactions
If you observe any of these symptoms after starting treatment with Tobrex (tobramycin ophthalmic), cease usage immediately and consult with a healthcare professional.
Contraindications for Gentamicin and Tobrex?
Both gentamicin and Tobrex (tobramycin), along with most other antibiotic eye drops, can cause severe allergic reactions in some people. If you notice symptoms such as itching, redness, swelling or pain increasing after using these medications, please seek immediate medical attention.
Neither gentamicin nor Tobrex should be taken if you are taking or have been taking certain types of drugs that may interact negatively with them. These include neuromuscular blocking agents or botulinum toxin. Always inform your physician about all the medications you are currently using to prevent dangerous drug interactions.
Furthermore, patients who have had a previous hypersensitivity reaction to any aminoglycoside antibiotics should not use either medication due to possible cross-sensitivity within the class of drugs.
How much do Gentamicin and Tobrex cost?
For the brand name versions of these drugs:
- The price of a 5ml bottle of Tobrex (0.3%) eye drops averages around $185, which can last for about a month depending on usage, working out to approximately $6/day.
- The price of a 2ml vial of Gentamicin (40mg/ml) is about $10, and depending on your dose and frequency could work out to less than $1 per day.
Thus, if you are using higher frequencies or dosages with Tobrex eye drops, then brand-name Gentamicin may be more cost-effective. However, please remember that cost should not be the primary consideration in determining which medication is right for you.
For the generic versions:
- Generic Tobramycin (comparable to Tobrex) costs range from $10 to $30 for a similar size bottle as above. This works out much cheaper than the branded product at just over one dollar per day at most.
- Generic Gentamicin prices vary widely but average around half that of the branded version making it very affordable.
Prices will vary based on insurance coverage and location as well as any discounts available from pharmacies or manufacturers. As always, consider both efficacy and potential side effects when choosing between treatments with your healthcare professional's guidance.
Popularity of Gentamicin and Tobrex
Gentamicin, an aminoglycoside antibiotic used to treat various types of bacterial infections, was estimated to have been prescribed to about 1.2 million people in the US in 2020. Gentamicin accounted for just over 8% of aminoglycoside antibiotic prescriptions in the US. It is most commonly used as an injectable form for severe systemic infections and it's use has been relatively stable over the last decade.
Tobramycin, including its brand versions such as Tobrex which is typically employed as an ophthalmic solution (eye drop) for treating bacterial eye infections such as conjunctivitis or keratitis, was prescribed to approximately 600 thousand people in the USA during 2020. Tobramycin accounts for around 6% of all topical antibiotics formulated specifically for ocular usage and it has seen a slight increase in prevalence since 2013 due to increasing rates of contact lens-associated microbial keratitis where it can be particularly effective.
Conclusion
Gentamicin and Tobrex (tobramycin) are both aminoglycoside antibiotics that have been used for decades to treat various bacterial infections, particularly those caused by Gram-negative bacteria. Both drugs work by inhibiting protein synthesis in bacteria, thereby killing them. They might be combined with other antibiotics depending on the type of infection being treated and the specific organism responsible.
The choice between gentamicin and Tobrex often comes down to the specific strain of bacteria causing an infection as well as patient-specific factors such as allergies or kidney function. In some cases, one drug may be more effective against a certain bacterium than the other.
Both medications come in multiple forms including injectable solutions and eye drops; however, it's important to note that they should not be interchanged without medical advice due to different potency levels. While gentamicin is generally less expensive which can represent significant cost savings especially for patients who must pay out of pocket, Tobrex has fewer reported side effects related to ototoxicity (ear damage).
As with all medications, potential side effects need monitoring when starting treatment with either medication; these include kidney toxicity and hearing loss. Patients experiencing signs such as dizziness or changes in urine production should seek immediate medical attention.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Laibson, P., Michaud, R., Smolin, G., Okumoto, M., Rosenthal, A., & Cagle, G. (1981, December). A Clinical Comparison of Tobramycin and Gentamicin Sulfate in the Treatment of Ocular Infections. American Journal of Ophthalmology. Elsevier BV.http://doi.org/10.1016/s0002-9394(14)75639-9
- Brogden, R. N., Pinder, R. M., Sawyer, P. R., Speight, T. M., & Avery, G. S. (1976). Tobramycin. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-197612030-00002
- Jackson, W. B., Low, D. E., Dattani, D., Whitsitt, P. F., Leeder, R. G., & MacDougall, R. (2002, June). Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops. Canadian Journal of Ophthalmology. Elsevier BV.http://doi.org/10.1016/s0008-4182(02)80114-4
- Cagle, G., Davis, S., Rosenthal, A., & Smith, J. (1981, January). Topical tobramycin and gentamicin sulfate in the treatment of ocular infections: multicenter study. Current Eye Research. Informa UK Limited.http://doi.org/10.3109/02713688109069178
- Klastersky, J., Hensgens, C., Henri, A., & Daneau, D. (1974, February). Comparative Clinical Study of Tobramycin and Gentamicin. Antimicrobial Agents and Chemotherapy. American Society for Microbiology.http://doi.org/10.1128/aac.5.2.133
- González‐Mendiola, M. R., García Balda, A., Ceña Delgado, M., Prieto Montaño, P., González De Olano, D., & Sánchez‐Cano, M. (2005, February 2). Contact allergy from tobramycin eyedrops. Allergy. Wiley.http://doi.org/10.1111/j.1398-9995.2005.00588.x
- Schretlen-Doherty, J. S., & Troutman, W. G. (1995, July). Tobramycin-Induced Hypersensitivity Reaction. Annals of Pharmacotherapy. SAGE Publications.http://doi.org/10.1177/106002809502907-810
- Leibowitz, H. M., Hyndiuk, R. A., Smolin, G. R., Nozik, R. A., Hunter, G. J., Cagle, G. D., & Davis, D. S. (1981, January). Tobramycin in external eye disease: a double-masked study vs. gentamicin. Current Eye Research. Informa UK Limited.http://doi.org/10.3109/02713688108999445
- Forgan-Smith, W. R., Andrew, J. H., & McSweeney, R. J. (1976). Gentamicin and tobramycin—an in vitro comparison using 1400 clinical isolates. Pathology. Elsevier BV.http://doi.org/10.3109/00313027609058999
- APPEL, G. B. (1978, October 1). Gentamicin in 1978. Annals of Internal Medicine. American College of Physicians.http://doi.org/10.7326/0003-4819-89-4-528
- Wargo, K. A., & Edwards, J. D. (2014, September 7). Aminoglycoside-Induced Nephrotoxicity. Journal of Pharmacy Practice. SAGE Publications.http://doi.org/10.1177/0897190014546836
- Notivol, R., Amin, D., Whitling, A., Wells, D., Kennedy, M., & Cockrum, P. C. (2004). Prophylactic Effectiveness of Tobramycin-Dexamethasone Eye Drops Compared with Tobramycin/Vehicle Eye Drops in Controlling Post-Surgical Inflammation in Cataract Patients. Clinical Drug Investigation. Springer Science and Business Media LLC.http://doi.org/10.2165/00044011-200424090-00003